SS
NAUT icon

SBI Securities’s Nautilus Biotechnolgy NAUT Stock Holding History

SBI Securities’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$187 Hold
100
– – ﹤0.01% 3348
2026
Q1 		$388 Buy
+100
New +$246 ﹤0.01% 2983

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

SBI Securities's NAUT Position: Q2 2026 in Review

SBI Securities held its Nautilus Biotechnolgy (NAUT) position steady in Q2 2026 at 100 shares worth $187. The position accounts for ﹤0.01% of the portfolio, ranked #3348.

SBI Securities first reported a position in NAUT in Q1 2026 and has held it in 2 quarters since. The position peaked at $388 in Q1 2026. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • SBI Securities held 100 shares of Nautilus Biotechnolgy worth $187 as of Q2 2026.
  • SBI Securities left its Nautilus Biotechnolgy share count unchanged in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3348 holding.
  • SBI Securities first reported a position in Nautilus Biotechnolgy in Q1 2026 and has held it in 2 quarters since.
  • SBI Securities's Nautilus Biotechnolgy position peaked at $388 in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.